Home » Search

Search Results

13895 results for 'articles'

To refine your search through our archives use our Advanced Search

A&E: Sing out your dead: ‘Evil’ musical at TOTS

“What happens next?” is a fundamental element of the theater. It’s a question that, if planted properly in the heads of audience members, keeps them enthusiastically coming back after intermission. But in “Evil Dead: the Musical,” the intermission question isn’t so much, “What happens next?” as it is, “What body part will be cut off next?” And, “How much of the spattering blood will reach me here in the third row?” I’m no fan of spoilers, so I won’t answer…

VIEWPOINT: Put progress over politics and enact reform

As we approach the final stretch in this year’s election season, it’s easy to get desensitized to the political rhetoric. Sometimes, though, there’s an issue that transcends the partisan divide and deserves to cut through the clutter: Local government reform is such an issue. Indiana’s Constitution created a multilayered system of county, township and municipal government in 1851. This might have been appropriate when most travel was by horseback, but today it’s left Hoosiers to support more than 3,000 units…

Former rocker rolling along in pizza business: Puccini’s founder has 13 locations and counting

For much of his adult life, Don Main was a rocker rather than a restaurateur. But fate-along with a pressing need to find a more profitable line of work-drove him to seek his fortune in a kitchen rather than onstage. Main, president and co-owner of Puccini’s Smiling Teeth, began his peculiar career change back in 1990, after a decadeand-a-half stint as a professional-but not very well-paid-musician. At age 36, the bassist and lead vocalist for the band The Late Show…

FUNNY BUSINESS: The art of letter writing: before the text generation

My sister’s kids, Deniece and Denephew, think it is just hilarious to watch their fumbling uncle trying to send a text message-which has recently become the No. 1 use of cell phones, instead of talking. I poke and prod one measly letter at a time. Meanwhile, the kids-with agile thumbs and secondnature knowledge of a cell phone touch pad-are incredible. To watch them is to see an intricate ballet of the opposable digits (pas de pouces) performed at lightning speed….

Naming-rights deal puts Lucas Oil in competitive position

Emboldened by the deal he signed to put his company’s name on the Indianapolis Colts’ new home, Forrest Lucas has launched
an arsenal of creative-some would say unorthodox-initiatives to fortify his growing company. Many of them are designed to
help Lucas Oil Products Inc. go head to head with the oil industry’s biggest players.

Ex-Lilly executives open ‘trials’ clinic: Centurion expects high demand from drug firms

A new clinic that is on the cusp of conducting human trials in Indianapolis could distinguish itself as a key player in drug development, not only within the state, but nationally as well. Centurion Clinical Research LLC serves pharmaceutical companies and medical-device makers that need to test their products before they can be approved for widespread use. That first phase, in which healthy people are paid to participate in the overnight studies, is critical in determining the safety and success…

Commentary: We’re all in danger of motion sickness

(Author’s note: I submitted this column Oct. 14, with full knowledge that the world may have come to an end by the time it is published.) It’s swing time. Candidates for office, state and federal, are swinging and slinging mud at one another. In a last-ditch effort to scare voters, Sarah Palin accused Barack Obama of hanging out with Bill Ayers, co-founder of the Weathermen, a militant group of the 1970s. In reality, by the time Ayers met Obama, his…

BEHIND THE NEWS: Lechleiter went toe to toe with Icahn to cut megadeal

Eli Lilly and Co. had been salivating over ImClone Systems Inc. for more than two years when, on July 25 of this year, its senior executives received a formal staff recommendation to contact the company and make an overture. So it must have come as quite a jolt to Lilly brass when, just six days later, Bristol-Myers Squibb announced that it was offering to buy the 83 percent of ImClone it didn’t already own for $60 a share, or $4.5…

VOICES FROM THE INDUSTRY: Worksite wellness encourages steps to healthier firm

Over the past several years, employers have seen a movement from traditional PPO health plans to consumer-driven health plans, by implementing qualified high-deductible plans such as health savings accounts. This shift has been viewed by most to have initially lowered overall employer and employee cost, but more importantly, it has gotten the employee more involved in their health care choices. Fortunately, consumer-driven health care plans are not the only answer in reducing employer costs. According to the Towers Perrin 2008…

ECONOMIC ANALYSIS: We shouldn’t let market mayhem obscure progress

Amid all this joyless market watching, this much is clear: The financial markets and the economy are going to get worse before they get better. But market watching is never a healthy sport, especially since it tends to make us lose track of the real economy at times like these. Over the past couple of weeks, the real economy has shown a bit of resilience. And here in Indiana, really great news has been lost in the wake of the…

VOICES FROM THE INDUSTRY: Taking a few minutes to take control of your health care

In recent months, all of us have been affected to some extent by economic uncertainty. At a time like this, we need to make well-informed decisions on how we spend our money, now and in the future. Health care spending is one area where people are looking more than ever to get the most value in return for their investment. The rising cost of health care should encourage everyone to explore their health benefit options. But despite rough economic times,…

You-review-it Monday

Truly moved by anything at the Heartland Film Festival? Catch Dance Kaleidoscope’s season opener? Visit a haunted house or, like me, were you part of the jury at the trial at the Benjamin Harrison Home?

So what did you get to…

Getrag loses main customer for Tipton plant

German manufacturer Getrag is without a primary customer for the transmissions it expected to make at a new factory in Tipton. Chrysler LLC terminated a financing options agreement with Getrag over the weekend, the company said. Indiana economic development officials hope Getrag can find a new customer soon for dual-clutch transmissions that were to be […]

Retail anchor leaving Lafayette Square

Sears Holdings Corp. has notified the state of plans to close its store at Lafayette Square Mall.The struggling retailer is laying off 110 employees at the department store and an automotive center at Lafayette Road and West 38th Street, due to “a change in business circumstances,” the company said in a notice filed yesterday with […]

Sears departure stings mall

The decision by Sears Holding Co. to close its store at Lafayette Square Mall could deal a serious blow to efforts by a New York…

Roche to cut 200 local jobs

Roche Diagnostics Corp. will cut 200 positions from its Indianapolis work force in what a spokeswoman called “a normal course of assessing the business.” Switzerland-based Roche, which makes medical devices such as glucose meters, employs roughly 2,600 people here as part of its North American headquarters and research-and-manufacturing operations. All of the cuts will come […]

Relocation firm relocating HQ to Fort Wayne

Global relocation giant Sirva Inc. announced plans this morning to centralize its national moving-services headquarters in Fort Wayne, creating 240 new jobs by 2011. It already employs 450 there. The firm, which operates Allied Van Lines and North American Van Lines, will invest more than $16 million to consolidate its Illinois-based national moving services operations […]

Report: Lilly drug decision unlikely before March

A pharmaceutical industry publication says the U.S. Food and Drug Administration is convening a February meeting to discuss prasugrel, a blood-thinner Eli Lilly and Co. hopes will be its next blockbuster. The move likely would delay a decision on the new drug until March, according to The Pink Sheet, a weekly publication that covers regulatory […]